Khaled Shalaby

Khaled Shalaby

Auto-generated profile, based on publicly available information

Khaled Shalaby

Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Drug Delivery
Verified
Journal Article
Open access
MEMohammed Elmowafy
Mohammed Elmowafy
HIHany M. Ibrahim
Hany M. Ibrahim
MAMohammed A. Ahmed
Mohammed A. Ahmed
KSKhaled Shalaby
Khaled Shalaby
ASAyman Salama
Ayman Salama
HHHossam Hefesha
Hossam Hefesha
Atorvastatin (AT) is a widely used lipid-regulating drug to reduce cholesterol and triglycerides. Its poor aqueous solubility and hepatic metabolism require development of drug delivery systems able to improve its solubility and bypass hepatic effect. For this purpose, atorvastatin nanostructured lipid carriers (AT-NLCs) were prepared and characterized. AT-NLCs were prepared by emulsification using high-speed homogenization followed by ultrasonication. The prepared NLCs showed particle size between 162.5 ± 12 and 865.55 ± 28 nm while zeta potential values varied between −34 ± 0.29 and −23 ± 0.36 mV. They also showed high encapsulation efficiency (>87%) and amorphous state of the drug in lipid matrix. Pharmacokinetic parameters of optimized formulation (NLC-1; composed of 2% Gelucire® 43/01, 8% Capryol® PGMC, 2% Pluronic®F68 and 0.5% lecithin) revealed 3.6- and 2.1-fold increase in bioavailability as compared to atorvastatin suspension and commercial product (Lipitor®), respectively. Administration of NLC-1 led to significant reduction (p < .05) in the rats’ serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and significant increase in high-density lipoprotein (HDL). This improvement was confirmed histologically by minimizing the associated hepatic steatosis. These investigations demonstrated the superiority of NLCs for improvement of oral bioavailability and in vivo performance of AT.

1 October 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MEMohammed Elmowafy
Mohammed Elmowafy
KSKhaled Shalaby
Khaled Shalaby
MBMohamed M. Badran
Mohamed M. Badran
HAHazim M Ali
Hazim M Ali
MAMohamed Sadek Abdel-Bakky
Mohamed Sadek Abdel-Bakky
HIHussein M. Ibrahim
Hussein M. Ibrahim

1 January 2012 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
MBMohamed Badran
Mohamed Badran
KSKhaled Shalaby
Khaled Shalaby
AAAbdullah Al-Omrani
Abdullah Al-Omrani
This study focuses on the effect of different flexible liposomes containing sodium cholate, Tween 80, or cineol on skin deposition of carboxyfluorescein (CF). Size distribution, morphology, zeta potential, and stability of the prepared vesicles were evaluated. The influence of these systems on the skin deposition of CF utilizing rat skin as membrane model was investigated. Results showed that all of the investigated liposomes had almost spherical shapes with low polydispersity (PDI < 0.3) and particles size range from 83 to 175 nm. All liposomal formulations exhibited negative zeta potential, good drug entrapment efficiency, and stability.In vitroskin deposition data showed that flexible liposomes gave significant deposition of CF on the skin compared to conventional liposomes and drug solutions. This study revealed that flexible liposomes, containing cineole, were able to deliver higher amount of CF suggesting that the hydrophilic drugs delivery to the skin was strictly correlated to the vesicle composition.

20 January 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
AMARAFA MUSA
ARAFA MUSA
SISaleh K. Ihmaid
Saleh K. Ihmaid
DHDavid L. Hughes
David L. Hughes
MSMusa Said
Musa Said
Hamada S. AbulkhairHamada S. Abulkhair
Hamada S. Abulkhair
AEAhmed El-Agrody
Ahmed El-Agrody
Treatment options for the management of breast cancer are still inadequate. This inadequacy is attributed to the lack of effective targeted medications, often resulting in the recurrence of metastatic disorders. Cumulative evidence suggests that epidermal growth factor receptor (EGFR-TK) and cyclin-dependent kinases-9 (CDK-9) overexpression correlates with worse overall survival in breast cancer patients. Pyranopyrazole and pyrazolone are privileged options for the development of anticancer agents. Inspired by this proven scientific fact, we report here the synthesis of two new series of suggested anticancer molecules incorporating both heterocycles together with their characterization by IR, 1H NMR, 13C NMR, 13C NMR-DEPT, and X-ray diffraction methods. An attempt to get the pyranopyrazole-gold complexes was conducted but unexpectedly yielded benzylidene-2,4-dihydro-3H-pyrazol-3-one instead. This unexpected result was confirmed by X-ray crystallographic analysis. All newly synthesized compounds were assessed for their anti-proliferative activity against two different human breast cancer cells, and the obtained results were compared with the reference drug Staurosporine. The target compounds revealed variable cytotoxicity with IC50 at a low micromolar range with superior selectivity indices. Target enzyme EGFR-TK and CDK-9 assays showed that compounds 22 and 23 effectively inhibited both biological targets with IC50 values of 0.143 and 0.121 µM, respectively. Molecular docking experiments and molecular dynamics simulation were also conducted to further rationalize the in vitro obtained results. Communicated by Ramaswamy H. Sarma

1 June 2018 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MEMohammed Elmowafy
Mohammed Elmowafy
KSKhaled Shalaby
Khaled Shalaby
MBMohamed M. Badran
Mohamed M. Badran
HAHazim M Ali
Hazim M Ali
MAMohamed Sadek Abdel-Bakky
Mohamed Sadek Abdel-Bakky
IEIbrahim El-Bagory
Ibrahim El-Bagory

1 June 2017 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
MEMohammed Elmowafy
Mohammed Elmowafy
ASAhmed Samy
Ahmed Samy
AAAbdelaziz E. Abdelaziz
Abdelaziz E. Abdelaziz
KSKhaled Shalaby
Khaled Shalaby
ASAyman Salama
Ayman Salama
MAMohamed A. Abdelgawad
Mohamed A. Abdelgawad
The study was conducted to evaluate the potential application of nanocapsules and nanospheres as topical drug delivery systems for indomethacin (as model drug). Both were prepared by nanoprecipitation using poly (ɛ-caprolactone) and hydroxypropyl β-cyclodextrin polymers and evaluated for morphology, particle size, zeta potential, EE% and in vitro drug release then incorporated in methylcellulose and Carbopol 940 gel bases and evaluated for in vitro release. The selected formulations and market product were evaluated for ex vivo human skin permeation and anti-inflammatory and analgesic activities by paw edema and hot plate methods respectively. Results showed that nanocapsules had slight higher EE% and larger particle sizes than nanospheres. In vitro release and zeta potential were nearly similar. Methylcellulose exhibited higher in vitro release than Carbopol 940 after 3 h (except NS2). Ex vivo skin permeation studies showed significant higher cumulative amount of IND (and flux) from NC1/MC and NS1/MC (1573.06 ± 14.23 µg/cm2 and 1452.24 ± 23.18 µg/cm2 respectively) than market product. They also showed enhancement ratio and permeability coefficient rate of ∼1.5 and ∼2 respectively. NC1/MC proved to be significantly higher pharmacodynamic effects than market product. All results showed that NC1/MC could provide a promising formula as a topical delivery of indomethacin